- Home
- INKT vs ANEB Comparison
INKT vs ANEB Comparison
Compare INKT & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- ANEB
- Stock Information
- Founded
- INKT 2017
- ANEB 2020
- Country
- INKT United States
- ANEB United States
- Employees
- INKT N/A
- ANEB N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- ANEB Health Care
- Exchange
- INKT Nasdaq
- ANEB Nasdaq
- Market Cap
- INKT 28.8M
- ANEB 39.0M
- IPO Year
- INKT 2021
- ANEB 2021
- Fundamental
- Price
- INKT $62.86
- ANEB $1.66
- Analyst Decision
- INKT Strong Buy
- ANEB Strong Buy
- Analyst Count
- INKT 2
- ANEB 2
- Target Price
- INKT $37.50
- ANEB $5.50
- AVG Volume (30 Days)
- INKT 2.4M
- ANEB 21.1K
- Earning Date
- INKT 08-12-2025
- ANEB 05-13-2025
- Dividend Yield
- INKT N/A
- ANEB N/A
- EPS Growth
- INKT N/A
- ANEB N/A
- EPS
- INKT N/A
- ANEB N/A
- Revenue
- INKT N/A
- ANEB N/A
- Revenue This Year
- INKT N/A
- ANEB N/A
- Revenue Next Year
- INKT N/A
- ANEB N/A
- P/E Ratio
- INKT N/A
- ANEB N/A
- Revenue Growth
- INKT N/A
- ANEB N/A
- 52 Week Low
- INKT $4.56
- ANEB $0.80
- 52 Week High
- INKT $76.00
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- INKT 57.39
- ANEB 59.78
- Support Level
- INKT $6.80
- ANEB $1.57
- Resistance Level
- INKT $7.88
- ANEB $2.00
- Average True Range (ATR)
- INKT 0.40
- ANEB 0.25
- MACD
- INKT 0.02
- ANEB 0.00
- Stochastic Oscillator
- INKT 58.86
- ANEB 30.25
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.